Edition:
United Kingdom

Menlo Therapeutics Inc (MNLO.OQ)

MNLO.OQ on NASDAQ Stock Exchange Global Select Market

33.92USD
5:53pm GMT
Change (% chg)

$-0.96 (-2.75%)
Prev Close
$34.88
Open
$34.24
Day's High
$35.09
Day's Low
$33.92
Volume
3,747
Avg. Vol
--
52-wk High
$38.01
52-wk Low
$20.50

Chart for

About

Menlo Therapeutics Inc. is a United States-based biopharmaceutical company. The Company is focused on the development and commercialization of serlopitant for the treatment of pruritus (itch) associated with dermatologic conditions, such as atopic dermatitis, psoriasis and prurigo nodularis. It is also evaluating the use of... (more)
No analyst recommendations are available for .

Overall

No Ratios Available.

Financials

  Industry Sector
P/E (TTM): -- 83.93 16.60
EPS (TTM): -- -- --
ROI: -- 1.66 10.66
ROE: -- 2.58 14.30

BRIEF-Novo Holdings Reports 5.05 Pct Passive Stake In Menlo Therapeutics

* NOVO HOLDINGS A/S REPORTS 5.05 PERCENT PASSIVE STAKE IN MENLO THERAPEUTICS INC, AS OF JANUARY 29, 2018 - SEC FILING‍​ Source text: (http://bit.ly/2nSBUJu) Further company coverage:

08 Feb 2018

BRIEF-Menlo Therapeutics Now Sees IPO Of 6.5 Mln Shares Of Common Stock Priced Between $16 And $17 Per Share

* MENLO THERAPEUTICS INC NOW SEES IPO OF 6.5 MILLION SHARES OF COMMON STOCK PRICED BETWEEN $16.00 AND $17.00 PER SHARE - SEC FILING

23 Jan 2018

Earnings vs. Estimates

No consensus analysis data available.